Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

NCT07228663 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hip Fracture Surgery
Cardiovascular Prevention
Venous Thromboembolism (VTE)

Interventions

DRUG: rivaroxaban and ASA
DRUG: Low-molecular weight heparin
DRUG: Fondaparinux
DRUG: Direct Oral Anticoagulant (DOAC)

Sponsor

McMaster University

Collaborators

[object Object]
[object Object]